Online Shopping Customer Service 0300 3033380*

Shopping Cart

Health Advice
Main Menu



Meningitis B Vaccine Deal Announced PDF Print Email

The Government has now reached agreement with GlaxoSmithKline (GSK) who produce the vaccine Bexsero that will allow all babies in the UK to be vaccinated against Meningitis B which is caused by meningococcal group B bacteria.  The vaccination programme now has the go-ahead to be made available on the NHS for every baby from two months old.  The committee responsible for the decision had previously ruled it was not cost effective.

As long as Bexsero can be provided at a cost-effective price, the meningitis B (Men B) vaccine will be given to babies as part of the routine childhood vaccination programme.


While Bexsero has been available privately for some time, the UK will become the first country in the world to introduce a national Men B vaccination routinely to its childhood programme.


In response to this announcement, Dr Ian Maconichie, Registrar, the Royal College of Paediatrics and Child Health said:

"I'm delighted that the meningitis B vaccine is going to be made available for all babies in the UK.

"Meningitis is a very serious infectious disease and is a leading killer of children and young people in the UK - one in ten cases prove fatal and of those who survive, many are left with life long disabilities.

"This decision will undoubtedly decrease mortality and morbidity rates and reduce the burden meningitis can have on children and their families."